AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountability for this by "bombarding" smaller companies with litigation it knows they won't be able to afford — a claim that medical IP lawyers have backed up.
Aloha McBride, EY global health leader, shared her perspective on AI adoption in healthcare. She called on company leaders to commit to AI at scale, but first they need to have a vision for what AI looks like for businesses.
Approval of Akebia Therapeutics' Vafseo is based on additional post-marketing safety data from Japan, where the drug has been used since 2020. The FDA rejected the drug two years ago due to concerns about cardiovascular safety.
Insurers should immediately end their overreach into medical decision-making and work with medical providers and their patients to ensure timely care for all.
In this episode of MedCity FemFwd, we're joined by Millicent Gorham, CEO of the Alliance for Women's Health and Prevention (AWHP). AWHP recently launched the EveryBODY Covered campaign, which is advocating for comprehensive coverage of obesity care. Gorham discusses the current state of obesity treatment for women and her goals for the campaign.
No comments